Skip to main content
Clinical Trials/DRKS00000525
DRKS00000525
Completed
Phase 3

Pain assessment in advanced dementia. Validity of the German PAINAD (= BESD) - A prospective double-blind randomised placebo-controlled trial - PAINAD II Study

Agaplesion Bethesda Klinik Ulm, Akademisches Krankenhaus der Universität Ulm0 sites45 target enrollmentAugust 24, 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
R52
Sponsor
Agaplesion Bethesda Klinik Ulm, Akademisches Krankenhaus der Universität Ulm
Enrollment
45
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 24, 2010
End Date
June 25, 2013
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Agaplesion Bethesda Klinik Ulm, Akademisches Krankenhaus der Universität Ulm

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of dementia (Alzheimer’s disease, vascular type and combined), non\-communicative patients MMSE \< 20, PAINAD\-G\-score \= 4 during activities, no analgesic medication or only medication of WHO – Stage I (will be continued unchanged), highly pain\-associated diseases (such as arthrosis, chronic back pain), informed consent of the guardian

Exclusion Criteria

  • Participation in different studies, cancer, other forms of dementia differing from the above, other diseases causing communication impairments (such as apoplexy, Parkinson’s, multiple sclerosis), analgesic medication of WHO – Stage II or III, adverse effect of Oxycodone and contra\- indication against Oxycodone according to the instruction leaflet

Outcomes

Primary Outcomes

Not specified

Similar Trials